Not Tagged
Not Tagged
['lcsm,(-blcsm)', 'pdl']
#oladimejiakinboro presents #fda pooled data on pdl1 &gt;50% showing same os for chemo-io and io, but pfs benefit for chemo-io, most pronounced in first 12 months. more info needed on high risk features for those that may benefit from chemo-io &gt; io in this subgroup. #lcsm #asco22 
Thoracic Medical Oncologist, University of Pennsylvania. Lung cancer and mesothelioma. Views are my own.